Analytical Reference Standards. High Quality Noramco-qualified Standards
|
|
|
- Josephine Allen
- 6 years ago
- Views:
Transcription
1 Analytical Reference Standards High Quality Noramco-qualified Standards
2 Highly characterized, highly purified standards The United States Food and Drug Administration requires reference-standard materials to be of the highest quality, and thoroughly characterized, to assure identity, strength, and quality. Noramco offers well-characterized, highly purified analytical reference standards for routine analysis, method validation and development, commercial investigations, stability studies and other product development activities. Noramco s reference standards program is focused on the synthesis of compounds of complex chemistry. Review our catalog of more than 175 reference standards. All reference materials may be ordered in a variety of quantities to meet your project requirements. Reference standard qualifications Noramco utilizes various sophisticated spectroscopic techniques to characterize each reference standard. Overall purity, or Purity Factor, is typically derived from 100% less the summation of inorganic, organic and solvent impurities. Table 1. Typical Certificate of Analysis includes: 1.0 Appearance 2.0 Identification 3.0 Inorganic impurities 4.0 Organic impurities 5.0 Solvent impurities 6.0 Purity factor All analytical reference standards include a signed certificate of analysis (CoA) and safety data sheet. The data within the CoA is based on information we believe to be highly accurate and reliable. Reference standards supplied by Noramco is intended only for analytical and research purposes and may not be used for human consumption. For reference standards technical support, contact our R&D department. Sample certificate of analysis
3 Amphetamine Salts Amphetamine Aspartate (CII) ** Amphetamine Formamide (NC) N-formylamphetamine ** Amphetamine Impurity 251 (NC) N/A ** Amphetamine Sulfate (CII) ** Dextroamphetamine Saccharate (CII) ** Dextroamphetamine Sulfate (CII) ** Dextroamphetamine Sulfate, < 98% EE (CII) NEW ** Phenylacetone (CII) USP Impurity B ** Buprenorphine Hydrochloride 15,16-Dehydrobuprenorphine Base (CII) ** 17,18-Dehydrobuprenorphine Base (CII) EP Impurity J ** 19,19 Ethenylbuprenorphine (CII) NEW EP Impurity F ** 2,2 -Bisbuprenorphine Base (CII) EP Impurity G ** 3-Deshydroxybuprenorphine Base (CII) N/A ** 3-O-Methylbuprenorphine Base (CII) EP Impurity D ** 3-O-Methyl-N-cyanonorbuprenorphine Base (CII) EP Impurity C ** 3-O-Methyl-N-methylnorbuprenorphine Base (CII) ** 3-O-Methylnorbuprenorphine Base (CII) ** 6-O-Desmethylbuprenorphine Base (CII) EP Impurity E ** Buprenorphine Base (CIII) ** Buprenorphine Hydrochloride (CIII) ** Buprenorphine N-Oxide (CII) ** N-But-3-enylnorbuprenorphine Base (CII) N-But-3-enylnormethylbuprenorphine Base (CII) USP Compound A; EP Impurity A 3-O-Methyl-N-(But-3-enyl) Norbuprenorphine Base (CII) ** N/A ** N-butylnorbuprenorphine (CII) NEW EP Impurity H ** N-Methylnorbuprenorphine Base (CII) ** Norbuprenorphine Hydrochloride (CII) EP Impurity B ** Tetramethylfuran Buprenorphine (CII) NEW EP Impurity I; THF Buprenorphine **
4 Cannabinoids Δ 9 -Tetrahydrocannabinol (THC) NEW ** Δ 9 -Tetrahydrocannabinolic Acid (THCA) NEW ** Cannabidiol (CBD) NEW ** Cannabidiolic Acid (CBDA) NEW ** Cannabichromene (CBC) NEW ** Cannabichromenic Acid (CBCA) NEW ** Δ 9 -Tetrahydrocannabivarin (THCV) NEW ** Δ 9 -Tetrahydrocannabiarinic Acid (THCVA) NEW ** Cannabidivarin (CBDV) NEW ** Cannabidivarinic Acid (CBDVA) NEW ** Cannabichromevarin (CBCV) NEW ** Cannabichromevarinic Acid (CBCVA) NEW ** Cannabigerol (CBG) NEW TBD Cannabigerolic Acid (CBGA) NEW ** Δ 8 -Tetrahydrocannabinol NEW ** Δ 9 -Tetrahydrocannabinol Naphthoylester NEW N/A ** Δ 8 -Tetrahydrocannabinol Naphthoylester NEW N/A ** 4-monobromo Cannabidiol NEW N/A TBD Cannabicyclolic Acid (CBLA) NEW TBD Dihydrocannabinol (DHC) Isomer I NEW N/A TBD Dihydrocannabinol (DHC) Isomer II NEW N/A TBD Exo-Tetrahydrocannabinol NEW TBD Cannabinol (CBN) NEW TBD Δ 9 -Tetrahydrocannabinol (THC)-Methyl Analogue NEW N/A TBD Codeine Phosphate 10-Hydroxycodeine Base (CII) EP Impurity E ** 14-Hydroxycodeine Base (CII) EP Impurity F ** a-codeimethine Base (CII) ** Codeine Base (CII) ** Codeine-6-methyl Ether Base (CII) O-Methylcodeine; EP Impurity A ** Codeinone Base (CII) ** Dimethylpseudomorphine Base (CII) EP Impurity C ** Morphine Base (CII) EP Impurity B ** Norcodeine Base (CII) ** Thebaine Alkaloid (CII) EP Impurity G **
5 Hydrocodone Bitartrate 10-Hydroxyhydrocodone Base (CII) ** 10-β-Hydroxyhydrocodone (CII) NEW ** 10-Ketohydrocodone Base (CII) ** 6-b-Tetrahydrothebaine Base (CII) EP Impurity G ** 8,14-dihydrothebaine (CII) EP Impurity J ** Codeine Base (CII) EP Impurity C ** Codeine-6-methyl Ether Base (CII) O-Methylcodeine; EP Impurity F ** Codeinone Base (CII) EP Impurity E ** Dihydrocodeine Base (CII) EP Impurity B, USP Impurity ** Dihydrothebainone Base (CII) USP Compound A ** Hydrocodone Aldol Dimer (CII) NEW N/A ** Hydrocodone Base (CII) ** Hydrocodone Bitartrate (CII) ** Hydrocodone N-Oxide (CII) ** Hydromorphone Hydrochloride (CII) EP Impurity K ** Methylene Bridged Hydromorphone Dimer Base (CII) N/A ** Methylene Bridged Morphine Dimer Base (CII) N/A ** Morphine Base (CII) EP Impurity A ** Morphine Sulfate (CII) ** Oxycodone Base (CII) EP Impurity D ** Oxycodone Hydrochloride (CII) ** Pseudohydrocodone Base (CII) N/A ** Thebaine Alkaloid (CII) EP Impurity I ** Hydromorphone Hydrochloride 6-b-Tetrahydrooripavine Base (CII) USP Impurity ** 8,14-Dihydrooripavine Base (CII) USP Impurity ** 8-Hydroxyhydromorphone (CII) USP Impurity ** Dihydromorphine Base (CI) USP Impurity, EP Impurity D ** Hydromorphone Hydrochloride (CII) ** Hydromorphone N-Oxide (CII) EP Impurity B, USP Impurity ** Hyrdromorphone Aldol Dimer HCl (CII) NEW N/A ** Morphine Base (CII) EP Impurity C, USP Impurity ** Morphinone Perchlorate (CII) USP Compound A ** Norhydromorphone Base (CII) ** Pseudodihydrooripavine Base (CII) N/A ** Pseudohydromorphone Base (CII) EP Impurity A, USP Impurity 2,2 -bishydromorphone N/A **
6 Methylphenidate Hydrochloride Ethylphenidate Hydrochloride (NC) USP Impurity, EP Impurity E ** Methylphenidate Hydrochloride (CII) ** Methylphenidate Hydrochloride, erythro isomer (CII) USP Impurity, EP Impurity B ** Ritalinic Acid (NC) USP Compound A; EP Impurity A ** Morphine Sulfate 10-Ketomorphine (CII) NEW ** 10- Hydroxymorphine (CII) NEW ** 14-hydroxymorphine Base (CII) ** Codeine Base (CII) EP Impurity A ** Morphine Base (CII) ** Morphine N-Oxide (CI) USP Compound A; EP Impurity F ** Morphine Sulfate (CII) ** Morphinone Perchlorate (CII) EP Impurity E ** Oripavine Base (CII) EP Impurity C ** Pseudomorphine Base (CII) USP Compound B; EP Impurity B 2,2 -bimorphine ** Naloxone 10-a-Hydroxynaloxone Base (CII) EP Impurity C N/A ** 10-b-Hydroxynaloxone Base (CII) EP Impurity F N/A ** 10-Ketonaloxone Base (CII) ** 3-O-Methylnaloxone (CII) NEW EP Impurity G ** 3-O-Allylnaloxone Hydrochloride (CII) EP Impurity B ** 7,8-Didehydronaloxone Base (CII) EP Impurity D ** Naloxone Base (NC) ** Naloxone Dimer (CII) EP Impurity E; 2,2 -bisnaloxone ** Naloxone Hydrochloride (NC) ** Naloxone N-Oxide (CII) ** Noroxymorphone Base (CII) EP Impurity A, USP Impurity ** Noroxymorphone Carbamate (CII) **
7 Naltrexone 10-Hydroxynaltrexone Base (CII) ** 10-Ketonaltrexone Base (CII) EP Impurity I ** 14-Hydroxy-17-cyclopropylmethylnormorphinone Base (CII) ** 2,2 -Bisnaltrexone Base (CII) EP Impurity D; Pseudonaltrexone ** 3-(Cyclopropylmethyl) Naltrexone Base (CII) EP Impurity E ** 3-O-Methylnaltrexone Base (CII) EP Impurity J ** 8-Hydroxynaltrexone Base (CII) N/A ** N-(3-Butenyl)-noroxymorphone Base (CII) USP Compound A; EP Impurity C ** Naltrexone Aldol Dimer Base (CII) ** Naltrexone Base (NC) ** Naltrexone Hydrochloride (NC) ** Noroxymorphone Base (CII) EP Impurity B ** Noroxymorphone Carbamate (CII) ** Oxymorphone Base (CII) ** Oxymorphone Hydrochloride (CII) ** Oxycodone Hydrochloride 10-Hydroxyoxycodone Base (CII) USP Impurity ** 10-Ketooxycodone Base (CII) ** 14-Hydroxycodeinone Base (CII) 7,8-Dihydro-14-hydroxycodeine Base (CII) USP Compound A; EP Impurity D 6-a-Oxycodol (USP); EP Impurity B ** ** 7,8-Dihydro-8,14-dihydroxycodeinone Base (CII) USP Impurity ** 7-Methyloxycodone Base (CII) ** Codeinone Base (CII) USP Compound C ** Hydrocodone Base (CII) EP Impurity E, USP Impurity ** Noroxycodone Hydrochloride (CII) EP Impurity C ** Noroxymorphone Base (CII) USP Impurity ** Oxycodone Aldol Dimer (CII) NEW N/A ** Oxycodone Base (CII) ** Oxycodone Ethyl Enolate (CII) ** Oxycodone Hydrochloride (CII) ** Oxycodone N-Oxide (CII) USP Compound B ** Oxymorphone Base (CII) EP Impurity A, USP Impurity ** Oxymorphone Hydrochloride (CII) ** Thebaine Alkaloid (CII) EP Impurity F **
8 Oxymorphone Hydrochloride 10-Hydroxyoxymorphone Base (CII) ** 10-Ketooxymorphone Base (CII) ** 14-a-Hydroxydihydromorphine Base (CI) ** 14-Hydroxycodeinone Base (CII) ** 14-Hydroxymorphinone Base (CII) ** 2,2 -Bisoxymorphone Base (CII) ** 4-Hydroxyoxymorphone Base (CII) N/A ** 4-Hydroxyoxymorphone HCl (CII) NEW N/A ** 8-Hydroxyoxymorphone Base (CII) ** Hydromorphone Hydrochloride (CII) ** Noroxymorphone Base (CII) ** Oxycodone Base (CII) ** Oxycodone Hydrochloride (CII) ** Oxymorphone Aldol Dimer (CII) NEW N/A ** Oxymorphone Base (CII) ** Oxymorphone Hydrochloride (CII) ** Oxymorphone N-Oxide (CII) ** Pyran Bridged Oxymorphone Dimer HCl (CII) N/A ** How to order analytical reference material All orders are managed and processed at Noramco s Athens, Georgia, location. Please send your contact details and electronic copies of the following forms to: Refstds@noramco.com For all orders, provide: 1. Purchase order 2. DEA form 222 for schedule I and II 3. Certificate of available procurement quota (if applicable) 4. Copy of DEA license (if ordering schedule 3 compounds) If placing an order for export, please include: 1. Letter of no objection, or import permit 2. A non re-export statement Companies holding a DEA license may now order reference standards products on our secure website. Contact us and apply for approval to gain access to the site. Noramco Analytical Services Group 1550 Olympic Drive Athens, GA Telephone: +1(706) Refstds@noramco.com This information is based on our present knowledge and is intended to provide notes on our products and their uses. It should not be construed as guaranteeing specific properties of the products described or their suitability for a particular application. Any existing industrial property rights must be observed. The quality of our products is warranted under our General Conditions of Sale. Copyright 2017 Noramco. All rights reserved v3
Analytical Reference Standards. High Quality Noramco-qualified Standards
Analytical Reference Standards High Quality Noramco-qualified Standards Highly characterized, highly purified standards The United States Food and Drug Administration requires reference-standard materials
Detection of cannabinoids in Cannabis sativa plants
Detection of cannabinoids in Cannabis sativa plants THCA CBCA CBDA THC CBD CBC Thin Layer Chromatography (TLC) Agilent Cannabichromene,CBC Cannabigerol, CBG (-)-Δ9-Tetrahydrocannabinol,THC Δ9- tetrahydro-cannabivarol,
Weeding out the myths on Medical Cannabis
Weeding out the myths on Medical Cannabis Presented by A/Prof David Allsop Lambert Initiative for Cannabinoid Therapeutics University of Sydney For Walk on the Wild Side 2016: Superstition or Evidence?
Customer Sample Type Method Technique
Sample ID 18A23000003 Cannabis Potency HPLC-UV Chemistry Cannabidivarin (CBD-V) 1.29 mg/dose Cannabidiol (CBD) 646.50 mg/dose Cannabigerol (CBG) Tetrahydrocannabivarin (THC-V) 24.7 mg/dose
Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection
Application Note Cannabis Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection Authors Mike Adams, Annette Roth, Sue D
Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system
Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 9 Infinity II/63B LC/TOF system Application Brief Authors Mike Adams, Karen Kaikaris, and A. Roth CWC Labs Joan Stevens, Sue D
Potency Claims - only as Accurate as your Reference Material
Potency Claims - only as Accurate as your Reference Material Challenges with unstable TC and related Cannabinoids By Mitzi Rettinger Cerilliant Corporation Why is accuracy of potency assignment is important?
Analytical Results SC Laboratories Oregon LLC ORELAP# 4133/OLCC# D SW 74th Ave Suite 110, Tigard, OR
Analytical s Sample Name: Tested for: Mistery Haze SoFresh Farms Compliance Testing - Flower Laboratory ID: 18A0026-03 Matrix: Useable Marijuana Sample Metrc ID: 1A4010300001E17000002017 Lot # RH R1 MH
Cannabis Testing Laboratory Solutions
Cannabis Testing Laboratory Solutions We are the cannabis testing instrument experts. When purchasing analytical equipment, it is important to know that you are not just buying an instrument but investing
Medicinal Marihuana Science, Redefined
Medicinal Marihuana Science, Redefined From Concept to Commercialization.... www.avantirx.com WELL BEYOND COMPLIANCE Medicinal Marihuana Science, Redefined... ARA Avanti Rx Analytics Inc. is a Health Canada
Extraction News Notes Blog
Extraction News Notes Blog www.infinitysupercritical.com BY: Infinity Supercritical Staff EG TAGS: Supercritical CO2 Oil Extraction, Cannabis, Oil Concentrates Sustainable Production of Cannabinoids with
Establishment of a New Drug Code for Marihuana Extract. AGENCY: Drug Enforcement Administration, Department of Justice.
This document is scheduled to be published in the Federal Register on 12/14/2016 and available online at https://federalregister.gov/d/2016-29941, and on FDsys.gov Billing Code 4410-09-P DEPARTMENT OF
(B) A testing laboratory shall analyze a sample of at least one half of one percent of the
ACTION: Final DATE: 08/14/2017 9:26 AM 3796:4-2-04 Testing laboratory analysis requirements. (A) A testing laboratory shall analyze a sample of at least one half of one percent of the net weight of the
(THC) Delta9-tetrahydrocannabinol:
(THC) Delta9-tetrahydrocannabinol: Most prominent compound found in the cannabis plant found in the 1960 s. THC binds to the CB1 and CB2 receptors causing a change in the function of the cell it is binding.
CHAPTER 206, Laws of 1981
1981 Senate Bill 604 Date published : April 20,1982 CHAPTER 206, Laws of 1981 AN ACT to repeal 161.14 (2) (g) and (4) (k), 161.16 (2) (c) and (d), (3) (em), (4) and (6) and 161.18 (2) and (3) (g); to renumber
Certificate of Analysis: Hemp Oil Liquid Emulsion-CE Product Name Hemp Oil Liquid Emulsion-CE Product Code BATCH LE17167 Date of Manufacture 28 July 2017 Botanical Source Industrial Hemp, grown and processed
Prescription Refills during an Emergency
Prescription Refills during an Emergency Many people depend on prescription medications as part of their daily routine. During an emergency, routines are frequently interrupted and people often face unusually
Customer: Stud Horse Mountain Extracts Type: Concentrate Instrument: HPLC-PDA Submitted: 09/22/17
Sample ID: WA35545-11 Batch ID: 6040 0890 6000 0320 State ID: 0888 3805 9244 7356 Customer: Stud Horse Mountain Extracts Type: Concentrate Instrument: HPLC-PDA Submitted: 09/22/17 Test Site: Tukwila, WA
Analytical Results SC Laboratories Oregon LLC ORELAP# 4133/OLCC# D SW 74th Ave Suite 110, Tigard, OR
Analytical s Sample Name: Tested for: Kosher Kush SoFresh Farms Compliance Testing - Flower Laboratory ID: 17L0024-01 Matrix: Useable Marijuana Sample Metrc ID: 1A4010300001E17000001878 Lot # Kosher Kush
Determination of Cannabinoid and Terpene Profiles in Cannabis Oils by Mid-Infrared Spectroscopy: 1. Cannabinoids
1 Brian C. Smith, Ph.D., Big Sur Scientific, brian@bigsurscientific.com, (508) 579-6514. Determination of Cannabinoid and Terpene Profiles in Cannabis Oils by Mid-Infrared Spectroscopy: 1. Cannabinoids
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,
Extraction, Isolation and Analysis of Cannabis Extract and Preparation
Extraction, Isolation and Analysis of Cannabis Extract and Preparation A S S O C.PROF. D R. N A R I SA K A M K AEN D I R EC TO R O F H E R BAL P H A R MACY C O L L EG E O F P H A R MACY, R A N G S I T
International Narcotics Control Board QUARTERLY STATISTICS OF IMPORTS AND EXPORTS OF NARCOTIC DRUGS
International Narcotics Control Board FORM A QUARTERLY STATISTICS OF IMPORTS AND EXPORTS OF NARCOTIC DRUGS Single Convention on Narcotic Drugs, 1961: Articles 1, 2, 13, 20 and 25. Protocol of 25 March
Analytical Results SC Laboratories Oregon LLC ORELAP# 4133/OLCC# D SW 74th Ave Suite 110, Tigard, OR
Sample Name: Tested for: Durban Poison SoFresh Farms Compliance - Usable Laboratory ID: 18D0006-02 Matrix: Useable Marijuana Sample Metrc ID: 1A4010300001E17000002419 Lot # GH R3 2017 DP Batch RFID: 1A4010300001E17000002400
Detection of cannabinoids and cannabinoid metabolites using gas chromatography with vacuum ultraviolet spectroscopy
Received: 10 October 2017 Revised: 6 November 2017 Accepted: 6 November 2017 DOI: 10.1002/sscp.201700005 APPLICATION NOTE Detection of cannabinoids and cannabinoid metabolites using gas chromatography
The Determination of CBD and General Cannabinoid Content in Hemp Oils Using HPLC with UV Detection
High Performance Liquid Chromatography No. HPLC-018 The Determination of CBD and General Cannabinoid Content in Hemp Oils Using HPLC with UV Detection Introduction Medical marijuana generally possesses
Potency, Terpenes and Pesticides Analysis Using High Resolution LC-MS/MS: Results and Comparison to Alternative Analytical Methodologies
Potency, Terpenes and Pesticides Analysis Using High Resolution LC-MS/MS: Results and Comparison to Alternative Analytical Methodologies Kris Chupka Director, Analytical Chemistry Next Frontier Biosciences
Understanding the STOP Act s 5- and 7-day prescribing limits
Revised Dec. 18, 2017 Understanding the STOP Act s 5- and 7-day prescribing limits The STOP Act s limits on initial prescriptions for acute pain and post-surgical will be in effect Jan. 1, 2018. This FAQs
Drugs of Abuse I Serum
Drugs of Abuse I Serum 2017-11 1.10 For quality monitoring of quantitative measurements by chromatographic methods These reference materials are produced on the basis of human matrices. The highly accurate
Cannabis Testing Laboratory Solutions
Cannabis Testing Laboratory Solutions We are the cannabis testing instrument experts. When purchasing analytical equipment, it is important to know that you are not just buying an instrument but investing
Appendix 3: Taking controlled and prescription drugs to other countries
Appendix 3: Taking controlled and prescription drugs to other countries Some patients receiving palliative care travel to other countries and they will need to take their medicines with them. Practitioners
International Narcotics Control Board
International Narcotics Control Board FORM B ANNUAL ESTIMATES OF REQUIREMENTS OF NARCOTIC DRUGS, MANUFACTURE OF SYNTHETIC DRUGS, OPIUM PRODUCTION AND CULTIVATION OF THE OPIUM POPPY FOR PURPOSES OTHER THAN
1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2
Guidance for Travellers to Thailand under Treatment Carrying Personal Medications Containing Narcotic Drugs/Psychotropic Substances into/out of Thailand This guidance issued by the Narcotics Control Division,
Overview of the Emerging Cannabis Industry
Overview of the Emerging Cannabis Industry and AIHA s Cannabis Industry Health and Safety Task Force Rob Kleinerman, MPH, CIH Chair AIHA Cannabis Industry Health and Safety Task Force DISCLAIMER The American
Certi cate of Analysis
Powered by 1 of 8 Strain: Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to
Certi cate of Analysis
Powered by 1 of 8 Strain: Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to
Certificate of Analysis
Matrix: N/A Page 1 of 6 Image Cannabinoids 0.004% Total THC Safety Pesticides - Pass Microbials - Pass Mycotoxins - Pass Heavy Metals - Pass Terpenes - NT Residual-Solvents - Pass Filth - Pass Water Activity
HOW DOES THE STOP ACT IMPACT YOU?
HOW DOES THE STOP ACT IMPACT YOU? HB 243: Strengthen Opioid Misuse Prevention (STOP) Act passed the General Assembly and was subsequently signed into law by Governor Roy Cooper on June 29, 2017. Several
Responding to the Opioid Addiction Epidemic
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist,
Cannabis: Therapeutic properties of the plant
Cannabis: Therapeutic properties of the plant Medicinal cannabis is still illegal to be used in South Africa. In a victory for marijuana users across South Africa, ConCourt has officially legalised cannabis
Page 1 of 5. Kriss Worthington. Honorable Mayor and Members of the City Council Councilmembers Kriss Worthington, Cheryl Davila, and Kate Harrison
Page 1 of 5 Kriss Worthington Councilmember, City of Berkeley, District 7 2180 Milvia Street, 5 th Floor, Berkeley, CA 94704 PHONE 510-981-7170, FAX 510-981-7177, EMAIL kworthington@cityofberkeley.info
International Narcotics Control Board
International Narcotics Control Board FORM B ANNUAL ESTIMATES OF REQUIREMENTS FOR NARCOTIC DRUGS, MANUFACTURE OF SYNTHETIC DRUGS, AND CULTIVATION OF THE OPIUM POPPY, THE CANNABIS PLANT AND THE COCA BUSH
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories
Urine Opioid Dependency Panel (UODP) 1
Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,
Marihuana Identification and THC Quantification Test No Summary Report
Collaborative Testing Services, Inc FORENSIC TESTING PROGRAM Marihuana Identification and THC Quantification Test. 17-503 Summary Report Each sample pack consisted of three questioned samples containing
INFUSED II LABORATORY REPORT
1 of 1 879 Federal Blvd Denver, CO 80204 (303) 427-2379 License Number: 405-00008 405R-00011 INFUSED II LABORATORY REPORT Customer Name: Customer License: Batch Number: METRC Tag: Instrument Name: Triple
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
1479..1494 BJP British Journal of Pharmacology DOI:10.1111/j.1476-5381.2010.01166.x www.brjpharmacol.org Themed Issue: Cannabinoids in Biology and Medicine, Part I RESEARCH PAPERbph_1166 Effects of cannabinoids
Medical Marijuana: High Expectations Dr. Ally Dering-Anderson, RP University of Nebraska College of Pharmacy. Speaker Contact Information
Medical Marijuana: High Expectations Dr. Ally Dering-Anderson, RP University of Nebraska College of Pharmacy Speaker Contact Information Dr. Ally Dering-Anderson, RP Clinical Associate Professor of Pharmacy
The cannabis plant (Cannabis sativa) is an annual
DRUG FORMULATIONS AND CLINICAL METHODS Gul et al.: Journal of AOAC International Vol. 98, No. 6, 2015 1523 Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using
Have approved and decreed: Chapter 1 Definitions
Decree of containing implementation rules pursuant to the Opium Act (Opium Act Decree) At the recommendation of Our Minister of Health, Welfare and Sport of 2 October 2002, No. 02.004519, made in accordance
Certi cate of Analysis
1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately empower
Certi cate of Analysis
Powered by 1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately
Certi cate of Analysis
Powered by 1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately
Certi cate of Analysis
1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately empower
Certi cate of Analysis
1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately empower
Certi cate of Analysis
1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately empower
Certi cate of Analysis
Powered by 1 of 8 Strain: Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to
Certi cate of Analysis
Powered by 1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately
3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG
1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia
NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date
Urine drug testing it s not always crystal clear
Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine
Certi cate of Analysis
Powered by 1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately
As Introduced. 132nd General Assembly Regular Session H. B. No Representative Ramos Cosponsors: Representatives Seitz, Fedor, Ashford
132nd General Assembly Regular Session H. B. No. 773 2017-2018 Representative Ramos Cosponsors: Representatives Seitz, Fedor, Ashford A B I L L To amend sections 3719.01 and 3796.20 and to enact section
PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R137-14
PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY LCB File No. R137-14 (This draft replaces the one posted 9/10/2014 and includes the requested changes from R138-14) NAC 453.530 Schedule III. (NRS 453.146,
Certi cate of Analysis
Powered by 1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately
Case 1:18-cv NYW Document 1-1 Filed 07/30/18 USDC Colorado Page 1 of 12 EXHIBIT A
Case 1:18-cv-01922-NYW Document 1-1 Filed 07/30/18 USDC Colorado Page 1 of 12 EXHIBIT A Case 1:18-cv-01922-NYW Document 1-1 Filed 07/30/18 USDC Colorado Page 2 of 12 I IIIII IIIIIIII Ill lllll lllll lllll
Certi cate of Analysis
1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately empower
Certi cate of Analysis
1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately empower
Certi cate of Analysis
1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately empower
Certi cate of Analysis
Powered by 1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Hammersmith Medicines Research Limited Cumberland Avenue Park Royal London NW10 7EW Contact: Juan Naveda Tel: +44 (0) 20 8961 4130 Fax: +44
10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?
Objectives Drug Testing Interpretation in Addiction Care Brandi Puet, Pharm.D. Describe the difference between immunoassay and confirmatory testing. List explanations for unexpected negative or positive
KASPER Quarterly Threshold Analysis Report, Second Quarter 2016
KASPER Quarterly Threshold Analysis Report, Second Quarter 26 The Kentucky All Schedule Prescription Electronic Reporting System (KASPER) Quarterly Threshold Analysis Report is produced under a Prescription
SUPPLEMENTAL AGENDA MATERIAL for Supplemental Packet 2
Page 1 of 6 Sophie Hahn Councilmember District 5 SUPPLEMENTAL AGENDA MATERIAL for Supplemental Packet 2 Meeting Date: July 10, 2018 Item Number: 19 Item Description: Ordinance Allowing Currently Permitted
Certi cate of Analysis
1 of 6 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately empower
New potential therapeutic applications for certain phytocannabinoids revealed by pharmacological discoveries Roger Pertwee
New potential therapeutic applications for certain phytocannabinoids revealed by pharmacological discoveries Roger Pertwee UNIVERSITY OF ABERDEEN Cannabis - a unique source of phytocannabinoids (at least
Certi cate of Analysis
Powered by 1 of 8 Dear Valued Colleague, Thank you for selecting C4 Laboratories. Our goal at C4 is to provide reliable data that is interpreted within the appropriate physiological context, to ultimately
Recommendations to Regulators: Cannabis Laboratory Operations July 2013
Recommendations to Regulators: Cannabis Laboratory Operations July 2013 The legal status of products derived from Cannabis spp. is in a transitional phase in many states in the United States. Where products
Analysis of Cannabinoids in Hemp Seed Oils by HPLC Using PDA Detection
APPLICATION NOTE Liquid Chromatography Authors: Catharine Layton Wilhad M. Reuter PerkinElmer, Inc. Shelton, CT Analysis of Cannabinoids in Hemp Seed Oils by HPLC Using PDA Detection Introduction Cannabis
Key Advantages of Comprehensive Cannabis Analysis
Comprehensive Cannabis Analysis: Pesticides, Aflatoxins, Terpenes, and High Linear Dynamic Range Potency from One Extract Using One Column and One Solvent System Robert Di Lorenzo 1, Diana Tran 2, KC Hyland
LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching
Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple
Responsibility through testing THE HANDBOOK. Understanding Your Laboratory
Responsibility through testing THE HANDBOOK Understanding Your Laboratory Table of Contents Page3...Welcome Page 4...Submitting Samples Page 5...Setting the Standard Page 6...Top 10 Questions Page 7...Cannabinoid
September HCMC Toxicology Transition: Additional information and Frequently Asked Questions
September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch
Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082
Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending
CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)
CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) Cat. No.: DTSJZ023 Pkg. Size: Intended Use The CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) is an immunochromatography based one step
Cannabis in the treatment of Autism:
Cannabis in the treatment of Autism: Are we ready? Deb Karhson, PhD and Lawrence Fung, MD, PhD Cannabis Anecdotal Data: Comparing Epilepsy and Autism+ Science of Cannabinoids: Endocannabinoid System Receptor
PHYTOCANNABINOIDS AND THEIR MEDICINAL APPLICATIONS
Toll Free: 1.800.516.1504 info@vitaliset.com vitaliset.com Find us on Instagram! vitalisextractiontech PHYTOCANNABINOIDS AND THEIR MEDICINAL APPLICATIONS A recent history of prejudice against the cannabis
Development of gas and liquid chromatographic methods for the separation and quantification of 11 cannabinoids
Development of gas and liquid chromatographic methods for the separation and quantification of 11 cannabinoids This thesis is presented for the degree of Bachelor of Science Honours, School of Veterinary
Marihuana Identification and THC Quantification Test No Summary Report
Collaborative Testing Services, Inc FORENSIC TESTING PROGRAM Marihuana Identification and THC Quantification Test. 18-503 Summary Report Each sample pack consisted of three questioned samples containing
APPLICATIONS TN A Comparison of Various Kinetex C18 Phases USP: L1
APPLICATIONS A Comparison of Various Kinetex C18 Phases Zeshan Aqeel and Jeff Layne Phenomenex, Inc., 411 Madrid Ave., Torrance, CA 91 USA Introduction When performing reversed phase LC separations, there
Improved Gas Chromatographic Quantification of Acidic and Neutral Cannabinoids
Improved Gas Chromatographic Quantification of Acidic and Neutral Cannabinoids Amanda Rigdon 1, Jack Cochran 1, Julie Kowalski 1, Corby Hilliard 1, Sara Minier 1 Restek, PA, USA 2 Trace Analytics, WA,
2017 STYLE GUIDELINES & GROWERS MANUAL PHOTO COURTESY EAST FORK CULTIVARS
& GROWERS MANUAL PHOTO COURTESY EAST FORK CULTIVARS CULTIVATION CLASSIC (n) The world s first & only cannabis competition exclusively for flower produced in Oregon free of synthetics, defining craft and
Drug Adherence Assessment Report
Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)
1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I
chedule II Controlled ubstances: Basics and Beyond James L. Besier, Ph.D., R.Ph., FAHP Adjunct Associate Professor College of Nursing Adjunct Assistant Professor James L. Winkle College of Pharmacy University
Controlled Substance Monitoring in the Age of the Opioid Epidemic
Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,
Urine Drug Testing Methods 3-5
Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry
Brian C. Smith, Ph.D. Chief Technical Officer Big Sur Scientific (508)
Measurement of Cannabinoid and Terpene Profiles in Cannabis Extracts by Mid-Infrared Spectroscopy Brian C. Smith, Ph.D. Chief Technical Officer Big Sur Scientific Brian@bigsurscientific.com (508) 579-6514
Laboratory Service Report
4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric
DEVELOPMENT OF A NEW EXTRACTION TECHNIQUE AND HPLC METHOD FOR THE ANALYSIS OF NON-PHYCHOACTIVE CANNABINOIDS IN FIBRE-TYPE CANNABIS SATIVA L.
DEVELOPMENT OF A NEW EXTRACTION TECHNIQUE AND HPLC METHOD FOR THE ANALYSIS OF NON-PHYCHOACTIVE CANNABINOIDS IN FIBRE-TYPE CANNABIS SATIVA L. Dr. Virginia Brighenti, Ph.D. Department of Life Sciences University